[ad_1] SAN DIEGO – Bexagliflozin was effective and well-tolerated in lowering hemoglobin A1 C in patients with diabetes and stage 3a / 3b CKD, according to ASN Kidney Week. "We run into …
Read More »Bexaglifozin in HbA1c in patients with diabetes and stage 3a / 3b CKD
